Versant Capital Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.7K | Buy |
90
+51
| +131% | +$11.2K | ﹤0.01% | 1540 |
|
|
2025
Q1 | $8.73K | Buy |
39
+11
| +39% | +$2.46K | ﹤0.01% | 1789 |
|
|
2024
Q4 | $9.17K | Buy |
28
+10
| +56% | +$3.28K | ﹤0.01% | 1446 |
|
|
2024
Q3 | $5.4K | Buy |
18
+10
| +125% | +$3K | ﹤0.01% | 1274 |
|
|
2024
Q2 | $2.64K | Sell |
8
-3
| -27% | -$988 | ﹤0.01% | 1434 |
|
|
2024
Q1 | $4.35K | Hold |
11
| – | – | ﹤0.01% | 1081 |
|
|
2023
Q4 | $3.87K | Hold |
11
| – | – | ﹤0.01% | 1060 |
|
|
2023
Q3 | $4.13K | Hold |
11
| – | – | ﹤0.01% | 1050 |
|
|
2023
Q2 | $4.21K | Buy |
11
+1
| +10% | +$382 | ﹤0.01% | 1099 |
|
|
2023
Q1 | $3.45K | Hold |
10
| – | – | ﹤0.01% | 1080 |
|
|
2022
Q4 | $2.35K | Hold |
10
| – | – | ﹤0.01% | 1096 |
|
|
2022
Q3 | $2K | Hold |
10
| – | – | ﹤0.01% | 1148 |
|
|
2022
Q2 | $3K | Hold |
10
| – | – | ﹤0.01% | 1041 |
|
|
2022
Q1 | $4K | Hold |
10
| – | – | ﹤0.01% | 993 |
|
|
2021
Q4 | $5K | Hold |
10
| – | – | ﹤0.01% | 924 |
|
|
2021
Q3 | $4K | Hold |
10
| – | – | ﹤0.01% | 988 |
|
|
2021
Q2 | $4K | Hold |
10
| – | – | ﹤0.01% | 994 |
|
|
2021
Q1 | $3K | Hold |
10
| – | – | ﹤0.01% | 1187 |
|
|
2020
Q4 | $2K | Hold |
10
| – | – | ﹤0.01% | 1163 |
|
|
2020
Q3 | $2K | Hold |
10
| – | – | ﹤0.01% | 1112 |
|
|
2020
Q2 | $2K | Hold |
10
| – | – | ﹤0.01% | 1104 |
|
|
2020
Q1 | $1K | Sell |
10
-46
| -82% | -$4.6K | ﹤0.01% | 1227 |
|
|
2019
Q4 | $8K | Hold |
56
| – | – | ﹤0.01% | 792 |
|
|
2019
Q3 | $7K | Sell |
56
-28
| -33% | -$3.5K | ﹤0.01% | 868 |
|
|
2019
Q2 | $10K | Sell |
84
-111
| -57% | -$13.2K | ﹤0.01% | 768 |
|
|
2019
Q1 | $21K | Sell |
195
-40
| -17% | -$4.31K | 0.01% | 599 |
|
|
2018
Q4 | $23K | Hold |
235
| – | – | 0.01% | 492 |
|
|
2018
Q3 | $29K | Hold |
235
| – | – | 0.01% | 470 |
|
|
2018
Q2 | $23K | Hold |
235
| – | – | 0.01% | 567 |
|
|
2018
Q1 | $20K | Hold |
235
| – | – | 0.01% | 635 |
|
|
2017
Q4 | $23K | Sell |
235
-3
| -1% | -$294 | 0.01% | 596 |
|
|
2017
Q3 | $22K | Sell |
238
-17
| -7% | -$1.57K | 0.01% | 555 |
|
|
2017
Q2 | $24K | Sell |
255
-68
| -21% | -$6.4K | 0.01% | 521 |
|
|
2017
Q1 | $26K | Sell |
323
-29
| -8% | -$2.33K | 0.01% | 495 |
|
|
2016
Q4 | $29K | Sell |
352
-62
| -15% | -$5.11K | 0.02% | 465 |
|
|
2016
Q3 | $30K | Sell |
414
-36
| -8% | -$2.61K | 0.02% | 431 |
|
|
2016
Q2 | $34K | Sell |
450
-28
| -6% | -$2.12K | 0.02% | 356 |
|
|
2016
Q1 | $33K | Sell |
478
-80
| -14% | -$5.52K | 0.02% | 354 |
|
|
2015
Q4 | $33K | Buy |
+558
| New | +$33K | 0.02% | 340 |
|